Breast cancer patients with a known deleterious mutation in BRCA1/BRCA2 are more likely to have a family history of breast cancer or ovarian cancer [28] and an earlier age of diagnosis than noncarrier patients [18,29]. The gene discussed is BRCA2; the disease is ovarian carcinoma.